BRCA1 and breast carcinoma: Another study with 89% of the population with breast cancer used next-generation sequencing analysis with a 94-gene panel and showed a total of 81 pathogenic/likely pathogenic mutations in 29% of patients including mutations in BRCA1, BRCA2.